Cargando…
Characterization of Immune Cell Subsets of Tumor Infiltrating Lymphocytes in Brain Metastases
SIMPLE SUMMARY: Brain metastases arising from breast cancers, occur in about 20% of women with a poor-survival outcome. Unfortunately, most patients survive only up to eighteen months from diagnosis. Therefore, there is an urgent need to understand how these cancers survive in the brain. It is thoug...
Autores principales: | Croft, Priyakshi Kalita-de, Chittoory, Haarika, Nguyen, Tam H., Saunus, Jodi M., Kim, Woo Gyeong, McCart Reed, Amy E., Lim, Malcolm, De Luca, Xavier M., Ferguson, Kaltin, Niland, Colleen, Mazzieri, Roberta, Dolcetti, Riccardo, Simpson, Peter T., Lakhani, Sunil R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150725/ https://www.ncbi.nlm.nih.gov/pubmed/34064871 http://dx.doi.org/10.3390/biology10050425 |
Ejemplares similares
-
Clinicopathologic significance of nuclear HER4 and phospho-YAP(S(127)) in human breast cancers and matching brain metastases
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2020) -
Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer
por: Adwal, Alaknanda, et al.
Publicado: (2020) -
LobSig is a multigene predictor of outcome in invasive lobular carcinoma
por: McCart Reed, Amy E., et al.
Publicado: (2019) -
Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases—From Biology to Clinical Utility
por: Kalita-de Croft, Priyakshi, et al.
Publicado: (2022) -
Innovative Therapeutic Strategies for Effective Treatment of Brain Metastases
por: Lim, Malcolm, et al.
Publicado: (2019)